Stories from Surgical Aesthetics
Friday, December 15, 2017 - 12:39
The addition of platelet-rich plasma (PRP) to fat grafts appears to increase longevity of the transplanted materials, but inconsistent preparation protocols make meaningful evaluation of outcomes difficult, according to a retrospective study published online in Plastic and Reconstructive Surgery—Global Open (December 6, 2017).
Friday, December 15, 2017 - 12:37
The U.S. Food and Drug Administration (FDA) has cleared Coolsculpting cryolipolysis treatment (Allergan) for improved appearance of lax tissue in conjunction with submental fat, or double chin, treatments. An 18-week clinical study of Coolsculpting using the CoolMini applicator for the treatment of submental fat found that 77 percent of patients showed improved appearance of lax tissue and 75 percent of patients reported their chins looked more toned following treatment.
Friday, December 15, 2017 - 12:35
eRelevance Corporation, an automated marketing service for small- to medium-size businesses, has hired John Finocchiaro as vice president of inside sales. Finocchiaro, who will lead and continue to build an inside sales team focused on tripling sales of the eRelevance customer marketing service over the next 12 months, brings 15 years experience to the position. Most recently, he was senior manager at Dude Sales. Prior to that, he served as VP of inside sales at Knowledge Tree.
Friday, December 15, 2017 - 12:32
Restoration Robotics, maker of the Artas Hair Restoration System, has announced that Mark L. Hair will join the company as chief financial officer, effective January 5, 2018. Hair brings more than 20 years of executive management, financial advisory, consulting, and public company experience to the position. Most recently, he served as vice president and chief accounting officer at ZELTIQ Aesthetics, where he was responsible for managing the company’s global accounting organization. Prior to ZELTIQ, he served as V.P. of finance at Accuray, as a private consultant for St.
Thursday, December 7, 2017 - 10:49
Revance Therapeutics’ DaxibotulinumtoxinA for Injection (RT002) achieved six-month duration in two pivotal SAKURA Phase 3 clinical studies for the treatment of glabellar lines. RT002 met its primary composite endpoint by delivering highly statistically significant improvement against placebo in reducing the severity of glabellar lines in both SAKURA 1 and SAKURA 2.
Thursday, December 7, 2017 - 10:46
The results of a national online survey of 1,010 teenagers (ages 15-19) revealed that acne has a negative impact on body image and self-esteem, leading to anxiety over using social media. Cutanea Life Sciences commissioned the survey, which was conducted by Harris Poll.
Thursday, December 7, 2017 - 10:44
The U.S. Food and Drug Administration (FDA) has cleared the DESCRIBE PFD Patch (Merz Aesthetics), a single-use, perfluorodecalin-infused clear patch used during laser treatment of tattoos, for all commonly used wavelengths for tattoo removal. The Patch, which is placed over tattoos prior to treatment, allows practitioners to perform rapid multiple laser passes in a single treatment session. It was previously cleared in April 2015 for use with the 755nm QS Alexandrite laser, which is effective in removal of tattoos with blue or black ink.
Thursday, December 7, 2017 - 10:41
Modernizing Medicine, a provider a specialty-specific, data-driven and cloud-based electronic health record (EHR) systems, is launching two new initiatives to better support providers and patients. The company is now working with OptimizeRX, which notifies healthcare providers (HCPs) of potential prescription savings and support information for their patients, and Xcertia, a collaborative dedicated to improving the quality, safety and effectiveness of mobile health applications, or apps.
Thursday, November 30, 2017 - 10:36
Soft tissue fillers are popular and effective tools for replacing lost volume in the face. The most common adverse event is bruising, particularly in patients who require injections to multiple areas. In an effort to reduce filler-related bruising, Hasan Galadari, MD, and Wolfgang Redka-Swoboda, MD, have developed a technique that allows practitioners to fill the cheek and tear trough through a single entry point injection site.
Thursday, November 30, 2017 - 10:33
Fat grafting offers reliable and lasting improvement for patients seeking chin augmentation, according to a new study published in Plastic and Reconstructive Surgery (December 2017). Filipe V. Basile, MD, and Antonio Roberto Basile, MD, plastic surgeons in Ribeirao Preto-SP, Brazil, performed a prospective study that included 42 patients: 32 women and 10 men (average age 28 years).
Thursday, November 30, 2017 - 10:31
Establishment Labs, maker of the Motiva implant for breast augmentation, and OBP Medical, creator of the ONETRAC Retractors, worked together to create the Motiva Ultralight LED, a single-use, cordless surgical retractor and measurement device with integrated light source and smoke evacuator developed specifically for use with Motiva implants. The retractors, which will be included in surgical kits for the Motiva implants, help to improve clinical efficiency and reduce the risk of infection and require no assembly or fiber optic cables.
Wednesday, November 29, 2017 - 13:12
Recent court rulings may be opening the door for the importation of FDA-approved drugs from abroad.By Alex R. Thiersch, JDOperating a medical aesthetic practice is expensive, and profit margins can be precarious, particularly when a business is in its beginning stages. It’s no surprise, therefore, that practice owners are always on the lookout for ways to save money. Some do this by engaging in a practice known as parallel importation—importing non-counterfeit products from another country—which allows them to save money on brand name drugs. As tempting as it sounds, parallel importation is...
Monday, November 27, 2017 - 09:12
The U.S. Food and Drug Administration has issued an alert reminding dermatologists, plastic surgeons and consumers that injectable silicone is not approved to enhance or augment the body. In a statement released on November 14, 2017, the agency warns that such use can lead to ongoing pain, infections, and serious injuries, such as scarring and permanent disfigurement, embolism, stroke and death.
Monday, November 27, 2017 - 09:10
Mice irradiated with ultraviolent radiation (UV) showed reduced neurogenesis in the hippocampus and increased corticosterone in the blood. A research team led by Professor Jin Ho Chung of the department of dermatology at Seoul National University Hospital (SNUH) analyzed neurogenesis as well as changes in synaptic proteins that connect neurons to neurons in the hippocampus of the brain after irradiating the mouse skin with UV for a total of six times over two weeks.
Monday, November 27, 2017 - 09:08
Modernizing Medicine’s modmed Kiosk has won the People’s Choice Award at the 6th UX Awards Summit. The awards recognize innovation in digital products and services. A native iPad application, modmed Kiosk is designed for patients to perform self-service tasks, such as completing patient intake forms, at the doctor’s office. Patients can tap through intuitive prompts on the iPad to instantly access and update their personal, medical and pharmacy information rather than filling out cumbersome paperwork.
Monday, November 27, 2017 - 09:05
Milestone Scientific, a developer of computerized drug delivery instruments, is planning to introduce a cosmetic injection instrument for delivery of botulinum toxins. The wireless electronic device, which uses comfort speed technology already available for dental Novocain injections, offers precise dosing with less pain upon injection. It includes a touchscreen interface and integrated electronic record-keeping capability.
Thursday, November 16, 2017 - 12:37
China Regenerative Medicine International (CRMI) has acquired Obagi Medical Products from Valeant Pharmaceuticals for $190 million in cash. CRMI, which operates seven production plants in mainland China and Hong Kong, specializes in the research, development and commercialization of innovative bio-medical, healthcare products and medical techniques. In a press release, the company noted that this acquisition will help pave the way for future development of its cosmeceutical business in both the U.S. and international markets.
Thursday, November 16, 2017 - 12:35
Obesity is associated with an increased risk of rosacea in women, according to a new study published in the December 2017 issue of the Journal of the American Academy of Dermatology. Authors Suyun Li, PhD, et al, identified 5,249 cases of rosacea diagnosed from 1991-2005 among 89,886 women who participated in the Nurses’ Health Study II. They found significant correlation between rosacea risk and higher body mass index (≥35), particularly among those who had gained weight after age 18.